Anderson RyanSenior Group Leader in Radiation Oncology University of Oxford
Sabine HovesSenior Scientist, Discovery Oncology Roche
Hazel JonesHead of Combination Therapies, Drug Development Office Cancer Research UK
Barry DaviesPrincipal Scientist AstraZeneca
Download the brochure to discover even more reasons why this is a meeting not to be missed.
The number one aim of this year's Tumour Model London meeting is to improve the predictability and translatability of preclinical oncology research.
If you are a preclinical oncologist, translational scientist or tumour model developer who is constantly striving to improve the predictive ability of basic oncology research and the translational success of their candidates, then you should be at Tumour Models London 2014.
With an in-depth focus on cutting edge in vivo and in vitro modelling best practice, you will discover how the movement towards more physiologically relevant models will better mimic the tumour environment, better represent the patient population and help you prioritise the best drug candidates.
|Full access to 2 full conference days||Presentations slides and material|
|Access to exhibition area||Discounted interactive workshop places|
|2 x Networking lunches||Collaborative problem solving groups|
|Speed Networking sessions|